• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌中磷脂的分布及临床意义。

Distribution and clinical relevance of phospholipids in hepatocellular carcinoma.

机构信息

Department of Biochemistry, Shanxi Medical University, Shanxi Province, Taiyuan, 030001, China.

Department of Pathology, University of Mississippi Medical Center, Jackson, MS, 39216, USA.

出版信息

Hepatol Int. 2020 Jul;14(4):544-555. doi: 10.1007/s12072-020-10056-8. Epub 2020 Jun 5.

DOI:10.1007/s12072-020-10056-8
PMID:32504407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7366576/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the most common liver cancer and featured with prominent disparity in incidence and mortality rate between male and female. It remains unclear whether alterations of phospholipids (PL) in hepatic tissues contribute to the pathogenesis, progression, and disparity of HCC.

METHODS

Using electrospray ionization mass spectrometry (ESI-MS), PL profiles including 320 individual phospholipid species in 13 PL classes were determined in paired samples from HCC and adjacent benign hepatic tissues (BHT).

RESULTS

(1) Concentrations of PLs in most of individual species, in subgroups and in total were decreased in HCC than in BHT in all studied population; (2) the number of individual PL species significantly different between HCC and BHT, and the number of PLs in six subgroups and in total decreased in HCC were more in male population than in female population; (3) panels of PL parameters (more in male population than in female population) were identified as biomarkers in differentiation of HCC from BHT, and in the prediction of pathological grade and clinical stage of HCC with high sensitivity, specificity, and accuracy.

CONCLUSION

It is concluded that alterations of PLs in hepatic tissues play important roles in pathogenesis, progression, and gender disparity of HCC.

摘要

背景

肝细胞癌(HCC)是最常见的肝癌,其发病率和死亡率在男性和女性之间存在显著差异。目前尚不清楚肝组织中磷脂(PL)的改变是否有助于 HCC 的发病机制、进展和性别差异。

方法

采用电喷雾电离质谱(ESI-MS)技术,对 13 种 PL 类别的 320 种个体磷脂物种的 PL 谱进行了测定,共采集了 HCC 及相邻良性肝组织(BHT)的配对样本。

结果

(1)在所有研究人群中,HCC 中大多数个体物种、亚组和总 PL 的浓度均低于 BHT;(2)HCC 与 BHT 之间存在显著差异的个体 PL 物种数量以及在 6 个亚组和总 PL 中减少的数量在男性人群中均多于女性人群;(3)PL 参数谱(男性人群多于女性人群)被鉴定为区分 HCC 和 BHT 的生物标志物,以及预测 HCC 的病理分级和临床分期具有高灵敏度、特异性和准确性。

结论

肝组织中 PL 的改变在 HCC 的发病机制、进展和性别差异中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/1180c8b15820/12072_2020_10056_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/e8cccca6c4f9/12072_2020_10056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/28b88922b878/12072_2020_10056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/07cb01fcd712/12072_2020_10056_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/1180c8b15820/12072_2020_10056_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/e8cccca6c4f9/12072_2020_10056_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/28b88922b878/12072_2020_10056_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/07cb01fcd712/12072_2020_10056_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/7366576/1180c8b15820/12072_2020_10056_Fig4_HTML.jpg

相似文献

1
Distribution and clinical relevance of phospholipids in hepatocellular carcinoma.肝癌中磷脂的分布及临床意义。
Hepatol Int. 2020 Jul;14(4):544-555. doi: 10.1007/s12072-020-10056-8. Epub 2020 Jun 5.
2
Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.溶血磷脂酰胆碱酰基转移酶 1 改变了磷脂组成并调节肝癌进展。
J Hepatol. 2013 Aug;59(2):292-9. doi: 10.1016/j.jhep.2013.02.030. Epub 2013 Apr 6.
3
Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.磷脂作为癌症标志物:基于质谱的分析。
Mass Spectrom Rev. 2018 Mar;37(2):107-138. doi: 10.1002/mas.21510. Epub 2016 Jun 8.
4
Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma.神经酰胺和多不饱和磷脂在人类肝细胞癌中显著减少。
Biochim Biophys Acta. 2016 Nov;1861(11):1767-1774. doi: 10.1016/j.bbalip.2016.08.014. Epub 2016 Aug 26.
5
[F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling.[F]肝癌的氟代胆碱PET/CT成像:与组织磷脂谱的放射病理学相关性
Mol Imaging Biol. 2017 Jun;19(3):446-455. doi: 10.1007/s11307-016-1020-3.
6
Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.非癌性肝细胞分泌的 CCN3 通过旁分泌作用增加信号传导并促进肝癌进展。
BMC Cancer. 2019 Apr 27;19(1):395. doi: 10.1186/s12885-019-5603-7.
7
Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.采用高清晰度质谱技术鉴定肝细胞癌的新型生物标志物:超高效液相色谱-四极杆飞行时间质谱和解吸电喷雾电离质谱成像。
Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1(Suppl 1):e8551. doi: 10.1002/rcm.8551. Epub 2019 Nov 6.
8
Oestrogen attenuates tumour progression in hepatocellular carcinoma.雌激素可减轻肝癌的肿瘤进展。
J Pathol. 2012 Oct;228(2):216-29. doi: 10.1002/path.4009. Epub 2012 May 2.
9
Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.超高效液相色谱-质谱联用技术对肝癌和肝硬化的代谢组学特征分析。
J Proteome Res. 2012 Feb 3;11(2):1217-27. doi: 10.1021/pr2009252. Epub 2012 Jan 18.
10
Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6.UBE2D1 的获得促进了肝细胞癌的进展,并与持续的 IL-6 引起的 DNA 损伤有关。
J Exp Clin Cancer Res. 2018 Nov 27;37(1):290. doi: 10.1186/s13046-018-0951-8.

引用本文的文献

1
Targeting mitochondrial phosphatidylethanolamine alters mitochondrial metabolism and proliferation in hepatocellular carcinoma.靶向线粒体磷脂酰乙醇胺可改变肝细胞癌中的线粒体代谢和增殖。
Res Sq. 2025 Jul 15:rs.3.rs-7042684. doi: 10.21203/rs.3.rs-7042684/v1.
2
Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β-catenin signaling and tumor growth.肝癌细胞的比较膜脂质组学研究揭示了二酰基甘油和神经酰胺作为 Wnt/β-连环蛋白信号和肿瘤生长的关键调节剂。
Mol Oncol. 2023 Nov;17(11):2314-2336. doi: 10.1002/1878-0261.13520. Epub 2023 Sep 20.
3
iPLA2β-Null Mice Show HCC Protection by an Induction of Cell-Cycle Arrest after Diethylnitrosamine Treatment.

本文引用的文献

1
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.甲胎蛋白在肝细胞癌中的生物学特性及意义。
Liver Int. 2019 Dec;39(12):2214-2229. doi: 10.1111/liv.14223. Epub 2019 Sep 11.
2
Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.鉴定和描述肝癌中性别二态性相关基因表达谱。
Oncol Rep. 2019 Sep;42(3):937-952. doi: 10.3892/or.2019.7217. Epub 2019 Jun 28.
3
Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients.
iPLA2β 基因敲除小鼠经二乙基亚硝胺处理后诱导细胞周期停滞而显示出对肝癌的保护作用。
Int J Mol Sci. 2022 Nov 9;23(22):13760. doi: 10.3390/ijms232213760.
4
Lipid alterations in chronic liver disease and liver cancer.慢性肝病和肝癌中的脂质改变。
JHEP Rep. 2022 Mar 26;4(6):100479. doi: 10.1016/j.jhepr.2022.100479. eCollection 2022 Jun.
5
The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients.细菌细胞、癌细胞系和癌症患者生物样本的磷脂膜组成。
Chem Sci. 2021 Sep 28;12(40):13273-13282. doi: 10.1039/d1sc03597e. eCollection 2021 Oct 20.
6
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.二乙基亚硝胺注射诱导的肝癌细胞中胆固醇、甘油三酯和神经酰胺的积累。
Lipids Health Dis. 2021 Oct 10;20(1):135. doi: 10.1186/s12944-021-01567-w.
肝硬化患者的磷脂谱与肝细胞癌风险及预后
Oncotarget. 2019 Mar 15;10(22):2161-2172. doi: 10.18632/oncotarget.26738.
4
Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers.肝细胞癌患者肝脏和血清脂质特征的比较促成了诊断和预后生物标志物的发现。
Oncotarget. 2017 Dec 13;9(4):5032-5043. doi: 10.18632/oncotarget.23494. eCollection 2018 Jan 12.
5
Lipidomics unveils the complexity of the lipidome in metabolic diseases.脂质组学揭示了代谢疾病中脂质组的复杂性。
Clin Transl Med. 2018 Jan 26;7(1):4. doi: 10.1186/s40169-018-0182-9.
6
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
7
Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.复发性三阴性乳腺癌(TNBC)组织中磷脂酰胆碱(32:1)的含量高于非复发性TNBC组织。
PLoS One. 2017 Aug 23;12(8):e0183724. doi: 10.1371/journal.pone.0183724. eCollection 2017.
8
Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.血清胆固醇酯/游离胆固醇比值在肝细胞癌中的诊断价值
Anticancer Res. 2017 Jul;37(7):3527-3535. doi: 10.21873/anticanres.11721.
9
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.《亚太地区肝细胞癌管理临床实践指南:2017年更新版》
Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15.
10
Biomarkers for Hepatocellular Carcinoma.肝细胞癌的生物标志物
Biomark Cancer. 2017 Feb 28;9:1-9. doi: 10.1177/1179299X16684640. eCollection 2017.